FDA
approval
· 2024-01-11
FDA Approved: OXALIPLATIN — Original Application (Meitheal Pharmaceuticals Inc.)
Summary
The FDA approved Meitheal Pharmaceuticals' original application for a generic oxaliplatin product used to treat colorectal cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OXALIPLATIN (OXALIPLATIN)